[Diagnostic sensitivity and specificity and positive predictive value in the mass screening for cancer].

J. Ohkawa

1988-07-01

Abstract:

What problem does this paper attempt to address?

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Liang Junyi,Wang Yueyang,Liu Bin,Dong Xiaohong,Cai Wenhui,Zhang Ning,Zhang Hong

DOI: https://doi.org/10.1007/s12035-024-04513-w

IF: 5.682

2024-01-01

Molecular Neurobiology

Abstract:The gut microbiota, the complex community of microorganisms that inhabit the gastrointestinal tract, has emerged as a key player in the pathogenesis of neurodegenerative disorders, including Alzheimer’s disease (AD). AD is characterized by progressive cognitive decline and neuronal loss, associated with the accumulation of amyloid-β plaques, neurofibrillary tangles, and neuroinflammation in the brain. Increasing evidence suggests that alterations in the composition and function of the gut microbiota, known as dysbiosis, may contribute to the development and progression of AD by modulating neuroinflammation, a chronic and maladaptive immune response in the central nervous system. This review aims to comprehensively analyze the current role of the gut microbiota in regulating neuroinflammation and glial cell function in AD. Its objective is to deepen our understanding of the pathogenesis of AD and to discuss the potential advantages and challenges of using gut microbiota modulation as a novel approach for the diagnosis, treatment, and prevention of AD.
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease

Peilin Sun,Lei Su,Hua Zhu,Xue Li,Yaxi Guo,Xiaopeng Du,Ling Zhang,Chuan Qin

DOI: https://doi.org/10.3390/microorganisms9112281

IF: 4.5

2021-11-02

Microorganisms

Abstract:In recent years, human gut microbiota have become one of the most promising areas of microorganism research; meanwhile, the inter-relation between the gut microbiota and various human diseases is a primary focus. As is demonstrated by the accumulating evidence, the gastrointestinal tract and central nervous system interact through the gut–brain axis, which includes neuronal, immune-mediated and metabolite-mediated pathways. Additionally, recent progress from both preclinical and clinical studies indicated that gut microbiota play a pivotal role in gut–brain interactions, whereas the imbalance of the gut microbiota composition may be associated with the pathogenesis of neurological diseases (particularly neurodegenerative diseases), the underlying mechanism of which is insufficiently studied. This review aims to highlight the relationship between gut microbiota and neurodegenerative diseases, and to contribute to our understanding of the function of gut microbiota in neurodegeneration, as well as their relevant mechanisms. Furthermore, we also discuss the current application and future prospects of microbiota-associated therapy, including probiotics and fecal microbiota transplantation (FMT), potentially shedding new light on the research of neurodegeneration.

microbiology
Chlorophyll power.

Michael Moyer

DOI: https://doi.org/10.1038/scientificamerican0909-17

Scientific American

Abstract:
Gut microbiota: the indispensable player in neurodegenerative diseases

Sen Li,Yuwei Cai,Shuo Wang,Lei Luo,Yu Zhang,Kai Huang,Xiao Guan

DOI: https://doi.org/10.1002/jsfa.13509

Abstract:As one of the most urgent social and health problems in the world, neurodegenerative diseases have always been of interest to researchers. However, the pathological mechanisms and therapeutic approaches are not achieved. In addition to the established roles of oxidative stress, inflammation and immune response, changes of gut microbiota are also closely related to the pathogenesis of neurodegenerative diseases. Gut microbiota is the central player of the gut-brain axis, the dynamic bidirectional communication pathway between gut microbiota and central nervous system, and emerging insights have confirmed its indispensability in the development of neurodegenerative diseases. In this review, we discuss the complex relationship between gut microbiota and the central nervous system from the perspective of the gut-brain axis; review the mechanism of microbiota for the modulation different neurodegenerative diseases and discuss how different dietary patterns affect neurodegenerative diseases via gut microbiota; and prospect the employment of gut microbiota in the therapeutic approach to those diseases. © 2024 Society of Chemical Industry.
A new threshold determination algorithm for SAW resonant sensors

Yang Yang,Chenrui Zhang,Xupeng Zhao,Xiaojun Ji,Ping Li,Y. Wen,Tao Han

DOI: https://doi.org/10.1109/ULTSYM.2017.8091994

2017-09-01

IUS

Abstract:Wireless SAW resonant sensors have been widely used in many applications, especially in harsh environment. The sensor is detected when the echo signal spectrum processed by Fourier transform exceeds a threshold. Because of complicated noise and electromagnetic interference in wireless channel, the threshold should be adaptive to interference in order to detect the sensor accurately. However, few researches have been reported on the threshold determination of SAW resonant sensors. The only reported minimum identification error probability method for SAW RFID-tags needs prior probability density functions of both the background noise and the signal. In addition, since the resonance frequency of sensor and the reading distance are unknown when the reading system interrogates a SAW resonant sensor, it is difficult to estimate the signal-to-noise ratio (SNR) in real-time before a threshold is determined. A false alarm means the detection of a sensor when it actually does not exist, and it will cause wrong frequency estimation in the reading system; so the false alarm is more unacceptable than the miss-detection. According to the constant false alarm rate (CFAR) method in radar signal processing, a threshold determination algorithm for SAW resonant sensors is proposed, which pursues the detection probability to reach a maximum in complicated noise, and only the probability density distribution of noise is needed to estimate in the algorithm.
Gut Microbes and Neuropathology: Is There a Causal Nexus?

Katherine Dinan,Timothy G. Dinan

DOI: https://doi.org/10.3390/pathogens11070796

IF: 3.7

2022-07-15

Pathogens

Abstract:The gut microbiota is a virtual organ which produces a myriad of molecules that the brain and other organs require. Humans and microbes are in a symbiotic relationship, we feed the microbes, and in turn, they provide us with essential molecules. Bacteroidetes and Firmicutes phyla account for around 80% of the total human gut microbiota, and approximately 1000 species of bacteria have been identified in the human gut. In adults, the main factors influencing microbiota structure are diet, exercise, stress, disease and medications. In this narrative review, we explore the involvement of the gut microbiota in Parkinson's disease, Alzheimer's disease, multiple sclerosis and autism, as these are such high-prevalence disorders. We focus on preclinical studies that increase the understanding of disease pathophysiology. We examine the potential for targeting the gut microbiota in the development of novel therapies and the limitations of the currently published clinical studies. We conclude that while the field shows enormous promise, further large-scale studies are required if a causal link between these disorders and gut microbes is to be definitively established.

microbiology
The Relationship Between the Gut Microbiome and Neurodegenerative Diseases

Xueling Zhu,Bo Li,Pengcheng Lou,Tingting Dai,Yang Chen,Aoxiang Zhuge,Yin Yuan,Lanjuan Li

DOI: https://doi.org/10.1007/s12264-021-00730-8

IF: 5.271

2021-07-03

Neuroscience Bulletin

Abstract:Abstract Many recent studies have shown that the gut microbiome plays important roles in human physiology and pathology. Also, microbiome-based therapies have been used to improve health status and treat diseases. In addition, aging and neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, have become topics of intense interest in biomedical research. Several researchers have explored the links between these topics to study the potential pathogenic or therapeutic effects of intestinal microbiota in disease. But the exact relationship between neurodegenerative diseases and gut microbiota remains unclear. As technology advances, new techniques for studying the microbiome will be developed and refined, and the relationship between diseases and gut microbiota will be revealed. This article summarizes the known interactions between the gut microbiome and neurodegenerative diseases, highlighting assay techniques for the gut microbiome, and we also discuss the potential therapeutic role of microbiome-based therapies in diseases.

neurosciences
Drugs and driving in Vienna, Austria.

Daniele Risser,M. Stichenwirth,N. Klupp,Barbara Schneider,Thomas Stimpfl,W. Vycudilik,Georg Bauer

DOI: https://doi.org/10.1520/JFS14312J

1998-07-01

Journal of Forensic Sciences

Abstract:Drugs that affect the central nervous system are generally assumed to have the potential to impair driving ability. In a retrospective survey, police files and the results of toxicological urine analysis from drivers suspected of driving under the influence of drugs in Vienna from 1993 to 1996 were investigated. Decisive for police intervention was "unsafe driving" (swerving, hesitating, going too slowly, etc.), driving at high speed within the city limits, driving through red lights or stop signs, and driving at night without lights. In one-fifth of the cases drivers caused a traffic accident. Casting suspicion on driving under influence of drugs was mainly caused by impaired coordination of movements, bloodshot eyes, slurred speech, drowsiness, conspicuous behavior, and changed pupils. In the majority of the study population more than two symptoms were recorded by police. In 94% of the cases police suspicions could be confirmed by toxicological urine analysis.
Gut Microbiota and Immune System Dynamics in Parkinson's and Alzheimer's Diseases

Natasa Kustrimovic,Sahar Balkhi,Giorgia Bilato,Lorenzo Mortara

DOI: https://doi.org/10.3390/ijms252212164

IF: 5.6

2024-11-14

International Journal of Molecular Sciences

Abstract:The gut microbiota, a diverse collection of microorganisms in the gastrointestinal tract, plays a critical role in regulating metabolic, immune, and cognitive functions. Disruptions in the composition of these microbial communities, termed dysbiosis, have been linked to various neurodegenerative diseases (NDs), such as Parkinson's disease (PD) and Alzheimer's disease (AD). One of the key pathological features of NDs is neuroinflammation, which involves the activation of microglia and peripheral immune cells. The gut microbiota modulates immune responses through the production of metabolites and interactions with immune cells, influencing the inflammatory processes within the central nervous system. This review explores the impact of gut dysbiosis on neuroinflammation, focusing on the roles of microglia, immune cells, and potential therapeutic strategies targeting the gut microbiota to alleviate neuroinflammatory processes in NDs.

biochemistry & molecular biology,chemistry, multidisciplinary
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside

Yuan-Yuan Ma,Xin Li,Jin-Tai Yu,Yan-Jiang Wang

DOI: https://doi.org/10.1186/s40035-024-00404-1

2024-02-28

Translational Neurodegeneration

Abstract:The aetiologies and origins of neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and Huntington's disease (HD), are complex and multifaceted. A growing body of evidence suggests that the gut microbiome plays crucial roles in the development and progression of neurodegenerative diseases. Clinicians have come to realize that therapeutics targeting the gut microbiome have the potential to halt the progression of neurodegenerative diseases. This narrative review examines the alterations in the gut microbiome in AD, PD, ALS and HD, highlighting the close relationship between the gut microbiome and the brain in neurodegenerative diseases. Processes that mediate the gut microbiome–brain communication in neurodegenerative diseases, including the immunological, vagus nerve and circulatory pathways, are evaluated. Furthermore, we summarize potential therapeutics for neurodegenerative diseases that modify the gut microbiome and its metabolites, including diets, probiotics and prebiotics, microbial metabolites, antibacterials and faecal microbiome transplantation. Finally, current challenges and future directions are discussed.

neurosciences
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle

Saravana Babu Chidambaram,Musthafa Mohamed Essa,A G Rathipriya,Muhammed Bishir,Bipul Ray,Arehally M Mahalakshmi,A H Tousif,Meena K Sakharkar,Rajpal Singh Kashyap,Robert P Friedland,Tanya M Monaghan

DOI: https://doi.org/10.1016/j.pharmthera.2021.107988

Abstract:The human microbiota comprises trillions of symbiotic microorganisms and is involved in regulating gastrointestinal (GI), immune, nervous system and metabolic homeostasis. Recent observations suggest a bidirectional communication between the gut microbiota and the brain via immune, circulatory and neural pathways, termed the Gut-Brain Axis (GBA). Alterations in gut microbiota composition, such as seen with an increased number of pathobionts and a decreased number of symbionts, termed gut dysbiosis or microbial intestinal dysbiosis, plays a prominent role in the pathogenesis of central nervous system (CNS)-related disorders. Clinical reports confirm that GI symptoms often precede neurological symptoms several years before the development of neurodegenerative diseases (NDDs). Pathologically, gut dysbiosis disrupts the integrity of the intestinal barrier leading to ingress of pathobionts and toxic metabolites into the systemic circulation causing GBA dysregulation. Subsequently, chronic neuroinflammation via dysregulated immune activation triggers the accumulation of neurotoxic misfolded proteins in and around CNS cells resulting in neuronal death. Emerging evidence links gut dysbiosis to the aggravation and/or spread of proteinopathies from the peripheral nervous system to the CNS and defective autophagy-mediated proteinopathies. This review summarizes the current understanding of the role of gut microbiota in NDDs, and highlights a vicious cycle of gut dysbiosis, immune-mediated chronic neuroinflammation, impaired autophagy and proteinopathies, which contributes to the development of neurodegeneration in Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis and frontotemporal lobar degeneration. We also discuss novel therapeutic strategies targeting the modulation of gut dysbiosis through prebiotics, probiotics, synbiotics or dietary interventions, and faecal microbial transplantation (FMT) in the management of NDDs.
Implications of Gut Microbiota in Neurodegenerative Diseases

Haoming Zhang,Yijia Chen,Zifan Wang,Gaijie Xie,Mingming Liu,Boyu Yuan,Hongxia Chai,Wei Wang,Ping Cheng

DOI: https://doi.org/10.3389/fimmu.2022.785644

IF: 7.3

2022-02-14

Frontiers in Immunology

Abstract:The morbidity associated with neurodegenerative diseases (NDs) is increasing, posing a threat to the mental and physical quality of life of humans. The crucial effect of microbiota on brain physiological processes is mediated through a bidirectional interaction, termed as the gut–brain axis (GBA), which is being investigated in studies. Many clinical and laboratory trials have indicated the importance of microbiota in the development of NDs via various microbial molecules that transmit from the gut to the brain across the GBA or nervous system. In this review, we summarize the implications of gut microbiota in ND, which will be beneficial for understanding the etiology and progression of NDs that may in turn help in developing ND interventions and clinical treatments for these diseases.

immunology
Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration

Riddhi Solanki,Anjali Karande,Prathibha Ranganathan

DOI: https://doi.org/10.3389/fneur.2023.1149618

IF: 3.4

2023-05-15

Frontiers in Neurology

Abstract:Alzheimer's disease (AD), is a chronic age-related progressive neurodegenerative disorder, characterized by neuroinflammation and extracellular aggregation of Aβ peptide. Alzheimer's affects every 1 in 14 individuals aged 65 years and above. Recent studies suggest that the intestinal microbiota plays a crucial role in modulating neuro-inflammation which in turn influences Aβ deposition. The gut and the brain interact with each other through the nervous system and chemical means via the blood-brain barrier, which is termed the Microbiota Gut Brain Axis (MGBA). It is suggested that the gut microbiota can impact the host's health, and numerous factors, such as nutrition, pharmacological interventions, lifestyle, and geographic location, can alter the gut microbiota composition. Although, the exact relationship between gut dysbiosis and AD is still elusive, several mechanisms have been proposed as drivers of gut dysbiosis and their implications in AD pathology, which include, action of bacteria that produce bacterial amyloids and lipopolysaccharides causing macrophage dysfunction leading to increased gut permeability, hyperimmune activation of inflammatory cytokines (IL-1β, IL-6, IL-8, and NLRP3), impairment of gut- blood brain barrier causing deposition of Aβ in the brain, etc. The study of micro-organisms associated with dysbiosis in AD with the aid of appropriate model organisms has recognized the phyla Bacteroidetes and Firmicutes which contain organisms of the genus Escherichia, Lactobacillus, Clostridium , etc., to contribute significantly to AD pathology. Modulating the gut microbiota by various means, such as the use of prebiotics, probiotics, antibiotics or fecal matter transplantation, is thought to be a potential therapeutic intervention for the treatment of AD. This review aims to summarize our current knowledge on possible mechanisms of gut microbiota dysbiosis, the role of gut brain microbiota axis in neuroinflammation, and the application of novel targeted therapeutic approaches that modulate the gut microbiota in treatment of AD.

neurosciences,clinical neurology
Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Iris Stolzer,Eveline Scherer,Patrick Süß,Veit Rothhammer,Beate Winner,Markus F Neurath,Claudia Günther

DOI: https://doi.org/10.3390/ijms241914925

2023-10-05

Abstract:The gut microbiome plays a pivotal role in maintaining human health, with numerous studies demonstrating that alterations in microbial compositions can significantly affect the development and progression of various immune-mediated diseases affecting both the digestive tract and the central nervous system (CNS). This complex interplay between the microbiota, the gut, and the CNS is referred to as the gut-brain axis. The role of the gut microbiota in the pathogenesis of neurodegenerative diseases has gained increasing attention in recent years, and evidence suggests that gut dysbiosis may contribute to disease development and progression. Clinical studies have shown alterations in the composition of the gut microbiota in multiple sclerosis patients, with a decrease in beneficial bacteria and an increase in pro-inflammatory bacteria. Furthermore, changes within the microbial community have been linked to the pathogenesis of Parkinson's disease and Alzheimer's disease. Microbiota-gut-brain communication can impact neurodegenerative diseases through various mechanisms, including the regulation of immune function, the production of microbial metabolites, as well as modulation of host-derived soluble factors. This review describes the current literature on the gut-brain axis and highlights novel communication systems that allow cross-talk between the gut microbiota and the host that might influence the pathogenesis of neuroinflammation and neurodegeneration.
Microbiome and metabolome insights into the role of the gastrointestinal-brain axis in neurodegenerative diseases: unveiling potential therapeutic targets

Helena U. Zacharias,Christoph Kaleta,Francois Cossais,Eva Schaeffer,Henry Berndt,Lena Best,Thomas Dost,Svea Glüsing,Mathieu Groussin,Mathilde Poyet,Sebastian Heinzel,Corinna Bang,Leonard Siebert,Tobias Demetrowitsch,Frank Leypoldt,Rainer Adelung,Thorsten Bartsch,Anja Bosy-Westphal,Karin Schwarz,Daniela Berg

DOI: https://doi.org/10.48550/arXiv.2208.09338

2022-08-19

Tissues and Organs

Abstract:Due to the aging of the world population and westernization of lifestyles, the prevalence of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) is rapidly rising and is expected to put a strong socioeconomic burden on health systems worldwide. Due to the limited success of clinical trials of therapies against neurodegenerative diseases, research has extended its scope to a systems medicine point of view, with a particular focus on the gastrointestinal-brain axis as a potential main actor in disease development and progression. Microbiome as well as metabolome studies along the gastrointestinal-brain axis have already revealed important insights into disease pathomechanisms. Both the microbiome and metabolome can be easily manipulated by dietary and lifestyle interventions, and might thus offer novel, readily available therapeutic options to prevent the onset as well as the progression of PD and AD. This review summarizes our current knowledge on the association between microbiota, metabolites, and neurodegeneration in light of the gastrointestinal-brain axis. In this context, we also illustrate state-of-the art methods of microbiome and metabolome research as well as metabolic modeling that facilitate the identification of disease pathomechanisms. We conclude our review with therapeutic options to modulate microbiome composition to prevent or delay neurodegeneration and illustrate potential future research directions to fight PD and AD.
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence

Xiaoyan Liu,Yi Liu,Junlin Liu,Hantao Zhang,Chaofan Shan,Yinglu Guo,Xun Gong,Mengmeng Cui,Xiubin Li,Min Tang

DOI: https://doi.org/10.4103/1673-5374.382223

2023-08-14

Neural Regeneration Research

Abstract:A growing body of evidence suggests that the gut microbiota contributes to the development of neurodegenerative diseases via the microbiota-gut-brain axis. As a contributing factor, microbiota dysbiosis always occurs in pathological changes of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. High-throughput sequencing technology has helped to reveal that the bidirectional communication between the central nervous system and the enteric nervous system is facilitated by the microbiota’s diverse microorganisms, and for both neuroimmune and neuroendocrine systems. Here, we summarize the bioinformatics analysis and wet-biology validation for the gut metagenomics in neurodegenerative diseases, with an emphasis on multi-omics studies and the gut virome. The pathogen-associated signaling biomarkers for identifying brain disorders and potential therapeutic targets are also elucidated. Finally, we discuss the role of diet, prebiotics, probiotics, postbiotics and exercise interventions in remodeling the microbiome and reducing the symptoms of neurodegenerative diseases.

neurosciences,cell biology
Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders

Małgorzata Anna Marć,Rafał Jastrząb,Jennifer Mytych

DOI: https://doi.org/10.3390/nu14193967

IF: 5.9

2022-09-25

Nutrients

Abstract:Herein we gathered updated knowledge regarding the alterations of gut microbiota (dysbiosis) and its correlation with human neurodegenerative and brain-related diseases, e.g., Alzheimer's and Parkinson's. This review underlines the importance of gut-derived metabolites and gut metabolic status as the main players in gut-brain crosstalk and their implications on the severity of neural conditions. Scientific evidence indicates that the administration of probiotic bacteria exerts beneficial and protective effects as reduced systemic inflammation, neuroinflammation, and inhibited neurodegeneration. The experimental results performed on animals, but also human clinical trials, show the importance of designing a novel microbiota-based probiotic dietary supplementation with the aim to prevent or ease the symptoms of Alzheimer's and Parkinson's diseases or other forms of dementia or neurodegeneration.

nutrition & dietetics
Effects of Gut Microbiota on Neurodegenerative Diseases

Saima Khatoon,Nida Kalam,Gulnaz Bano,Sumayah Rashid

DOI: https://doi.org/10.3389/fnagi.2023.1145241

IF: 4.8

2023-05-30

Frontiers in Aging Neuroscience

Abstract:A progressive degradation of the brain's structure and function, which results in a reduction in cognitive and motor skills, characterizes neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). The morbidity linked to NDs is growing, which poses a severe threat to human being's mental and physical ability to live well. The gut-brain axis (GBA) is now known to have a crucial role in the emergence of NDs. The gut microbiota is a conduit for the GBA, a two-way communication system between the gut and the brain. The myriad microorganisms that make up the gut microbiota can affect brain physiology by transmitting numerous microbial chemicals from the gut to the brain via the GBA or neurological system. The synthesis of neurotransmitters, the immunological response, and the metabolism of lipids and glucose have all been demonstrated to be impacted by alterations in the gut microbiota, such as an imbalance of helpful and harmful bacteria. In order to develop innovative interventions and clinical therapies for NDs, it is crucial to comprehend the participation of the gut microbiota in these conditions. In addition to using antibiotics and other drugs to target particular bacterial species that may be a factor in NDs, this also includes using probiotics and other fecal microbiota transplantation to maintain a healthy gut microbiota. In conclusion, the examination of the GBA can aid in understanding the etiology and development of NDs, which may benefit the improvement of clinical treatments for these disorders and ND interventions. This review indicates existing knowledge about the involvement of microbiota present in the gut in NDs and potential treatment options.

neurosciences,geriatrics & gerontology,gerontology
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

Eamonn M. M. Quigley

DOI: https://doi.org/10.1007/s11910-017-0802-6

2017-10-17

Current Neurology and Neuroscience Reports

Abstract:Purpose of ReviewThe purposes of this review were as follows: first, to provide an overview of the gut microbiota and its interactions with the gut and the central nervous system (the microbiota-gut-brain axis) in health, second, to review the relevance of this axis to the pathogenesis of neurodegenerative diseases, such as Parkinson’s disease, and, finally, to assess the potential for microbiota-targeted therapies.Recent FindingsWork on animal models has established the microbiota-gut-brain axis as a real phenomenon; to date, the evidence for its operation in man has been limited and has been confronted by considerable logistical challenges. Animal and translational models have incriminated a disturbed gut microbiota in a number of CNS disorders, including Parkinson’s disease; data from human studies is scanty. While a theoretical basis can be developed for the use of microbiota-directed therapies in neurodegenerative disorders, support is yet to come from high-quality clinical trials.SummaryIn theory, a role for the microbiota-gut-brain axis is highly plausible; clinical confirmation is awaited.

neurosciences,clinical neurology

[Diagnostic sensitivity and specificity and positive predictive value in the mass screening for cancer].

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease

Chlorophyll power.

Gut microbiota: the indispensable player in neurodegenerative diseases

A new threshold determination algorithm for SAW resonant sensors

Gut Microbes and Neuropathology: Is There a Causal Nexus?

The Relationship Between the Gut Microbiome and Neurodegenerative Diseases

Drugs and driving in Vienna, Austria.

Gut Microbiota and Immune System Dynamics in Parkinson's and Alzheimer's Diseases

Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside

Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle

Implications of Gut Microbiota in Neurodegenerative Diseases

Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration

Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Microbiome and metabolome insights into the role of the gastrointestinal-brain axis in neurodegenerative diseases: unveiling potential therapeutic targets

Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence

Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders

Effects of Gut Microbiota on Neurodegenerative Diseases

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases